Earlier versions of this R01 grant focused on the role of transcription factors inmediating depression-related behavioral abnormalities in animal models. We werethe first to implicate CREB in stress models and antidepressant responses. Morerecently, over the past 10 years, we have similarly defined the actions of ?FosB indetermining an animal's susceptibility vs. resilience to chronic stress. We have alsoused a range of genome-wide assays to define the target genes of these transcriptionfactors. These evolving datasets suggest the central involvement of glutamatergicneurotransmission within the nucleus accumbens (NAc), a key brain reward region,in governing these distinct responses to stress. Thus, for this competitive renewalapplication, we propose to utilize this novel insight to define how alteredglutamatergic signaling in NAc controls stress susceptibility vs. resilience. We usestate-of-the-art optogenetic tools to activate or suppress specific glutamatergicinputs to NAc and investigate the effect of these manipulations on both thedevelopment of stress-related behavioral abnormalities as well as their expression.We present robust preliminary evidence that different glutamatergic inputs alterstress vulnerability in very different ways. For example, acute optogeneticactivationof the prelimbic prefrontal cortex (PFC) promotes resilience, while acute activationof the ventral subiculum (vSUB) or medial thalamus promotes susceptibility. Asanother example, induction of long-term depression (LTD) specifically at vSUBsynapses dramatically enhances resilience, while LTD at infralimbic PFC synapsesmay enhance susceptibility. These data set the stage for a uniquely comprehensiveanalysis of how different glutamatergic inputs to NAc differentially control stressresponses. The second part of this R01 investigates the role of several prominenttarget genes, arising from our genome-wide assays and not previously implicated instress responses, in mediating post- and presynaptic forms of glutamatergicplasticity in NAc. Together, the proposed studies will shed fundamental light oncircuit-level mechanisms in stress susceptibility and resilience, and validate a seriesof new targets for the development of better treatments for depression and otherstress-related disorders.

Public Health Relevance

We believe that the best way to ultimately develop improved diagnostic tests and treatments for depression and other stress-related illnesses is through a better understanding of the basic biological mechanisms involved. This R01 grant renewal will contribute importantly to this goal by defining novel circuit mechanisms, and their molecular underpinnings, involved in depression-related phenomena.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH051399-23
Application #
8691147
Study Section
Special Emphasis Panel (ZRG1-MDCN-G (91))
Program Officer
Nadler, Laurie S
Project Start
1994-09-30
Project End
2019-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
23
Fiscal Year
2014
Total Cost
$489,431
Indirect Cost
$200,681
Name
Icahn School of Medicine at Mount Sinai
Department
Neurosciences
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Snyder, Gretchen L; Vanover, Kimberly E; Zhu, Hongwen et al. (2015) Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl) 232:605-21
Nestler, Eric J (2015) ?FosB: a transcriptional regulator of stress and antidepressant responses. Eur J Pharmacol 753:66-72
Sarkar, Ambalika; Chachra, Parul; Kennedy, Pamela et al. (2014) Hippocampal HDAC4 contributes to postnatal fluoxetine-evoked depression-like behavior. Neuropsychopharmacology 39:2221-32
Nomaru, Hiroko; Sakumi, Kunihiko; Katogi, Atsuhisa et al. (2014) Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia. Glia 62:1284-98
Nestler, Eric J (2014) Epigenetic mechanisms of depression. JAMA Psychiatry 71:454-6
Bagot, Rosemary C; Labonté, Benoit; Peña, Catherine J et al. (2014) Epigenetic signaling in psychiatric disorders: stress and depression. Dialogues Clin Neurosci 16:281-95
Donahue, Rachel J; Muschamp, John W; Russo, Scott J et al. (2014) Effects of striatal ?FosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychiatry 76:550-8
Der-Avakian, Andre; Mazei-Robison, Michelle S; Kesby, James P et al. (2014) Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response. Biol Psychiatry 76:542-9
Vialou, Vincent; Bagot, Rosemary C; Cahill, Michael E et al. (2014) Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ?FosB. J Neurosci 34:3878-87
Robison, A J; Vialou, Vincent; Sun, Hao-Sheng et al. (2014) Fluoxetine epigenetically alters the CaMKII* promoter in nucleus accumbens to regulate ýýFosB binding and antidepressant effects. Neuropsychopharmacology 39:1178-86

Showing the most recent 10 out of 54 publications